Healthy adult vaccination: An urgent need to prevent hepatitis B in China

References

• Bureau of disease prevention and control of Ministry of health, Chinese Center for disease control and prevention. Sero-epidemiological survey of hepatitis B among national population. Beijing: People's Medical Press; 2011
   Google Scholar
• Cheng Li, Shu-qin Duan, Shaohong Yan. Epidemiology of hepatitis B in Inner Mongolia autonomous region, 1991–2010. Disease Surveillance 2012; 27(1):20-24.
   Google Scholar
• Jingmin Zhang. Hepatitis B in Leshan, 2007–2011. J Preventive Med Information 2013; 29(1):43-6.
   Google Scholar
• Hua Ke, Ling Chai. Epidemiological analysis on viral hepatitis B in Yunxian County of Hubei from 2004–2011. Occupation Health 2013; 29(6):742-3.
   Google Scholar
• Zhou B, Cao DQ, Zhang YH, et al. Epide-miological characteristics of viral hepatitis in Mentou district of Beijing. Capital J Public Health 2011; 5:14-7.
   Google Scholar
• Jiaye Liu, Bingyu Yan, Zhang Li, et al. Comparison on the Antibody Response and Influenced Factors of Hepatitis B Vacine Made by Recombinant Dexyribonucleic Acid Techniques among Adults. Chinese J Vaccines Immunization 2013; 19(2):142-6.
   Google Scholar
• Li J, Yao J, Shan H, Chen Y, Jiang ZG, Ren JJ, Xu KJ, Ruan B, Yang SG, Wang B, et al. Comparison of the effect of two different doses of recombinant hepatitis B vaccine on immunogenicity in healthy adults. Hum Vaccin Immunother 2015; 11(5):1108-13.; PMID:25607773
   PubMed Web of Science ®Google Scholar
• Bin Lin, Kefen Zeng, Liang Xue, et al. Survey on Adult HBV Infection Rate and Influence Factor in Karamay City. Practical Preventive Medicine 2006; 13(5): 1195-7.
   Google Scholar
• Zhang W, Lin CY, Han Lili, Li LQ, Gao P, Lin H, Gong XH, Huang F, Tang YQ, Ma JX, et al. Study on the immuno-effects and influencing factors of Chinese Hamster Ovary (CHO) cell hepatitis B vaccine among adults, under different dosages. Chinese J Epidemiol 2010; 31(7):767-70.; PMID:21162840
   PubMedGoogle Scholar
• Li Li, Xiaofeng Liang. The present status and countermeasures of controlling Chinese hepatitis A and B. Disease Surveillance 2009; 24(5):307-12.
   Google Scholar
• Zhicheng Dai, Guoming Qi. Sero-epidemiological survey of viral hepatitis in China (1992–1995) (Vol. I). Beijing: Science Press; 1997
   Google Scholar
• Bureau of disease prevention and control, National Health and Family Commission of People's Republic of China. http://www.nhfpc.gov.cn/jkj/s3582/201307/518216575e544109b2caca07fca3b430.shtml. Published July 26, 2013
   Google Scholar
• Yanyang Zhang, Jun Li, Ying Ye, et al. Epidemic analysis of hepatitis B in Henan province in 2013. Chronic Pathematol J 2014; 15(5): 352-6.
   Google Scholar
• Shu Zhang, Jing Sun. Epidemiology of hepatitis B in Liaoning province. Chinese J Public Health Management 2014; 30(3):392-3.
   Google Scholar
• Fujie Shen, Min Shu, Shu Wang, et al. Analysis on epidemiological characteristics of acute viral hepatitis in Huangpu District of Shanghai from 2007–2012. Occupation Health 2014; 30(14):1925-7.
   Google Scholar
• Xuejian Liu, Xin Liu, Peilin Luo, et al. Analysis of the Epidemiological Characteristics of Hepatitis B in Xuyi from 2009 to 2013. Chinese Primary Health Care 2014; 28(7):114-5.
   Google Scholar
• Jianfei Gao, Hongxing Zhang, Aihong Zhang. Analysis of the Epidemiological Characteristics of Hepatitis B in Rudong from 2005 to 2011. Shanghai J Preventive Med 2014; 24(7):373-4.
   Google Scholar
• Shan Qi, Yi Zhi, Xingya Lin, et al. Analysis of the Epidemiological Characteristics of Hepatitis B in XuZhou from 2007–2010. Jiangsu J Preventive Medicine 2012; 23(1):43-4.
   Google Scholar
• Haihong Feng. Analysis of the Epidemiological Characteristics of Hepatitis B in Guangyun from 2005–2012. Jiangsu Health Care 2013; 15(4):11-2.
   Google Scholar
• Huanzhang Yuan, Xie Liu, Jinjun Wen. Analysis of the Epidemiological Characteristics of Hepatitis B in Dongwan from 2007–2011. South China J Preventive Medicine 2013; 39(5):44-6.
   Google Scholar
• Siyu Wang. Analysis of the Epidemiological Characteristics of Hepatitis B in Dongliao county from 2008–2012. China Practical Medicine 2013; 8(26):258
   Google Scholar
• Qimin Huang. Epidemiological analysis on viral hepatitis B in Nanjing City from 2008–2012. Occupation Health 2014; 30(7):940-1.
   Google Scholar
• Liusha Xue. Analysis on epidemiological characteristics of virus hepatitis in Mengshan County of Guangxi from 2006–2011. Occupation Health 2013; 29(14):1782-4.
   Google Scholar
• Jian Zhou, Yanyan Jiang, Lin Sun. Analysis on the epidemiological trend of hepatitis B from 1990 to 2011 in Weifang city. Progress Microbiol Immunol 2013; 41(6):51-4.
   Google Scholar
• Jinsheng Wen, Qining Cao. The Safety and efficacy after immunization with recombinant hepatitis B vaccine in infants. Jiangxi Medical J 2009; 44 (6):608-9.
   Google Scholar
• Zhongtai Cui, Shuxia Lin, yan Yan. An Analysis of the Effect of Domestic Recombinant Yeast Heptatitis B Vaccine of Different Doses. Health Med Res Practice 2011; 8 (1):46-4749.
   Google Scholar
• Ren JJ, Dai XW, Jiang ZG, Shen LZ, Chen YD, Li Q, Ren W, Liu Y, Yao J, Li LJ. Immunological effects of a 10-μg dose of domestic hepatitis B vaccine in adults. J Zhejiang Univ Sci B 2012; 13(11):948-54.; PMID:23125088
   PubMed Web of Science ®Google Scholar
• Yinzhong Chen, Renjie Jiang, Jinjin Shen, et al. Observation on the Anti-HBs of Different Genetic Engineering Hepatitis B Vaccine in Adults. Chinese J Vaccines Immunization 2007; 13 (4): 320-4.
   Google Scholar
• Shuyi An, Hui Jia, Yue F, et al. Meta-analysis on immunological effect of recombinant yeast hepatitis B vaccine with different doses. Chinese J Health Statistics 2009; 26 (4):398-9.
   Google Scholar
• Li J, Yao J, Shan H, Chen Y, Jiang ZG, Ren JJ, Xu KJ, Ruan B, Yang SG, Wang B, et al. Comparison of the effect of two different doses of recombinant hepatitis B vaccine on immunogenicity in healthy adults. Hum Vaccin Immunother 2015; 11(5):1108-13.; PMID:25607773
   PubMed Web of Science ®Google Scholar
• Shizhu Chen. The present status and problems of hepatitis B vaccine immune. World Chinese J Digestol 2006; 14 (27):2661-7.
   Google Scholar
• Saltoglu N, Inal AS, Tasova Y, Kandemir O. Comparison of the accelerated and classic vaccination schedules against hepatitis B: three-week hepatitis B vaccination schedule provides immediate and protective immunity. Ann Clin Microbiol Antimicrob 2003; 2:1201-6.
   Google Scholar
• Halperin SA, Dobson S, McNeil S, Langley JM, Smith B, McCall-Sani R, Levitt D, Nest GV, Gennevois D, Eiden JJ. Comparison of the safety and immunogenicity of hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide and a licensed hepatitis B vaccine in healthy young adults. Vaccine 2006; 24(1):20-6.; PMID:16198027
   PubMed Web of Science ®Google Scholar
• Halperin SA, McNeil S, Langley JM, Smith B, MacKinnon-Cameron D, McCall-Sani R, Heyward WL, Martin JT. Safety and immunogenicity of different two-dose regimens of an investigational hepatitis B vaccine (hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide) in healthy young adults. Vaccine 2012; 30(36):5445-8.; PMID:22704926; http://dx.doi.org/10.1016/j.vaccine.2012.05.074
   PubMed Web of Science ®Google Scholar
• Yao J, Li J, Chen Y, Shan H, Dai XW, Yang LN, Jiang ZG, Ren JJ, Xu KJ, Ruan B, et al. The response of hepatitis B vaccination on seronegative adults with different vaccination schedules. Hum Vaccin Immunother 2015; 11(5):1102-7.; PMID:25621975
   PubMed Web of Science ®Google Scholar
• Soroosh P, Shokri F, Azizi M, Jeddi-Tehrani M. Analysis of T-cell receptor β chain variable gene segment usage in healthy adult responders and nonresponders to recombinant hepatitis B vaccine. Scand J Immunol 2003; 57(5):423-31.; PMID:12753498; http://dx.doi.org/10.1046/j.1365-3083.2003.01256.x
   PubMed Web of Science ®Google Scholar
• Amirzargar AA, Mohseni N, Shokrgozar MA, Arjang Z, Ahmadi N, Yousefi Behzadi M, Amanzadeh A, Shokri F. HLA-DRB1, DQA1 and DQB1 alleles and haplotypes frequencies in Iranian healthy adult responders and non-responders to recombinant hepatitis B vaccine. Iran J Immunol 2008; 5(2):92-9.; PMID:18523354
   PubMedGoogle Scholar
• Chaoshuang Lin, Shibin Xie, Jing Liu, et al. Effect of revaccination using different schemes among adults with low or undetectable anti-HBs titers after hepatitis B virus vaccination. Clin Vaccine Immunol 2010; 17(10):1548-51.; http://dx.doi.org/10.1128/CVI.00064-10
   PubMed Web of Science ®Google Scholar
• Pan HX, Zeng Y, Song XF, Zhang YJ, Xu K, Liang ZL, Zhu FC. Immune response to hepatitis B vaccine with high antigen content in non-responders after standard primary vaccination in Chinese adults. Vaccine 2014; 32(29):3706-12.; PMID:24681228; http://dx.doi.org/10.1016/j.vaccine.2014.02.094
   PubMed Web of Science ®Google Scholar
• Vermeiren AP, Hoebe CJ, Dukers-Muijrers NH. High non-responsiveness of males and the elderly to standard hepatitis B vaccination among a large cohort of healthy employees. J Clin Virol 2013; 58(1):262-4.; PMID:23895931; http://dx.doi.org/10.1016/j.jcv.2013.07.003
   PubMed Web of Science ®Google Scholar
• Lin C, Zhu J, Zheng Y, Chen Y, Wu Z, Chong Y, Gao Z. Effect of GM-CSF in combination with hepatitis B vaccine on revacination of healthy adult non-responders. J Infect 2010; 60(4):264-70..; PMID:20138189; http://dx.doi.org/10.1016/j.jinf.2010.01.011
   PubMed Web of Science ®Google Scholar
• Zhu JQ, Huang ZY, Mao DB. Immunoreaction levels of revaccination in healthy population with hepatitis B vaccine. Zhongguo Yi Miao He Mian Yi 2009; 15(2):152-8.; PMID:20077662
   PubMedGoogle Scholar
• Hongwu Wang, Benxiao Luan, Lu Jia. The immune effect of hepatitis B vaccination in adults of: 9 year observation. J Preventive Medicine Anhui 2004; 10 (2): 84-85.
   Google Scholar
• West DJ. Vaccine-induced HBsAg immune memories: its relationship with booster immunization strategy. Foreign Medicine Section Biol Products Prophylaxis Diagnosis Therapy 1997; 20(3): 84-85.
   Google Scholar
• PJ Lu, O'Halloran A, Williams WW. Impact of Health Insurance Status on Vaccination Coverage among Adult Populations. Am J Prev Med 2015; 48(6):647-61.; PMID:25890684; http://dx.doi.org/10.1016/j.amepre.2014.12.008
   PubMed Web of Science ®Google Scholar
• Xiaoqiu Qi, Wang Yu, Jingjin Yu, et al. National population hepatitis B Sero-epidemiological survey report. Beijing: People's Medical Press; 2011.
   Google Scholar
• Xu F, He F, Zhou BQ, Zhao QY, Yan R. Observation on immunization effect of hepatitis B vaccine in adults by different dosages and schedules. Disease Surveillance 2013; 28(1):38-41.
   Google Scholar
• Chen SY, Wang XC, Dong XL, Xu HT, Wang FD, Tang ZF, Wang XL, Fan JL. Effects of two immunization schedules of recombinant yeast-derived hepatitis B vaccines for adults. Chin Prev Med 2013; 14(2):96-8.
   Google Scholar
• Yuan YB, Wang ZQ, Ma XP, Zhang GH. Comparison of the immunogenicity of different dosages of recombinant yeast-derived hepatitis B vaccines in adults. J Prev Med Chin PLA 2003; 21(3):176-9.
   Google Scholar
• Qi Y, Yang J, Ge GH. Different doses of recombinant hepatitis B vaccine on the immune effects of adult. Guide China Med 2011; 9(23):25-6.
   Google Scholar